Relationship between clinical efficacy on asthma treated by scarring moxibustion and fester capacity

摘要

目的

探讨化脓灸治疗过敏性哮喘中化脓量和疗效的关系.

方法

随机分为化脓灸9 壮组, 化脓灸3 壮组和化脓灸6 壮组, 观察灸疮最大面积、灸疮脱痂时间、灸疮初始化脓时间、灸疮结疤时间和各组临床疗效.

结果

9 壮组的灸疮最大面积明显大于3壮组, 与 6 壮组无显著差异, 而各组灸后灸疮脱痂时间 灸疮初始化脓时间和灸疮结疤时间无显著差异, 临床疗效显示9壮组明显优于3 壮组, 而与6 壮组无显著差异.

结论

化脓灸治疗过敏性哮喘中化脓量的多少和疗效有关, 一定的化脓量是化脓灸治疗哮喘取效的关键.

Abstract

Objective

To investigate the relationship between fester capacity and clinical efficacy on allergic asthma treated by scarring moxibustion.

Methods

The patients were randomly divided into scarring moxibustion 9-cone group, 3-cone group and 6-cone group. The biggest area, scab-lost time, first-festering time and scarring time of moxibustion sore, and the clinical efficacy in each group was observed.

Results

The biggest post-moxibustion sore area in 9-cone group was larger than that in 3-cone group, but had no difference in comparison with 6-cone group; the scab-lost time, first-festering time and scarring time of post-moxibustion sore in each group were of no difference. The clinical efficacy was better in 9-cone group than in 3-cone group, but had no difference in comparison with the 6-cone group.

Conclusion

Fester capacity in treating allergic asthma by scarring moxibustion is related to the clinical efficacy and definite fester capacity is the key to good results on allergic asthma.